Our team is composed of experts in the field of life sciences and a track record in Biotech Companies
Founders & Management Team
CEO and co-Founder
Extensive international experience in tech transfer and innovation with proven track record of portfolio management, IPR negotiation, technology licensing agreements with the pharmaceutical industry, creation of spin-offs, and negotiations with investors.
PhD Biomedicine, University of Barcelona.
Innovation expert with >10 years of experience managing cutting-edge innovation projects. Specialized in new business development in
cross-cultural environments. Solid competence
in generating strategic alliances and project management. Previous experience leading operations in oncology start-ups.
Head of R+D
RNA therapeutics expert with >15 years of experience in fundamental and translational research, leading projects and teams in the field of RNAi, antisense therapeutics, aptamers and nucleic acid conjugates.
PhD Life Sciences, University of Cambridge.
CSO and co-Founder
Principal investigator at IDIBELL with >25 years experience in biomedical research and childhood sarcomas. KOL in Ewing sarcoma. Experience in clinical trial design, having participated in two Phase I and one Phase II clinical trials.
PhD Biochemistry, Autonomous University of Barcelona.
Senior Scientist & Project Manager
Cristina Figueras Puig
Scientific Advisory Board
Aptamer Development Advisor
PhD in Pharmacology and Cancer Biology at Duke University. She is an Associate Professor at the University of Iowa and has been Director of Research at Moderna Therapeutics. She is an internationally recognized expert in oligonucleotide therapeutics and delivery. She has 60+ publications/9+ patents related to the development of novel RNA-based therapies for many diseases.
Juan Martín Liberal
PhD in Biomedicine at University of Barcelona. He is an experienced medical and consultant oncologist at Catalan Institut of Oncology (ICO). Juan has worked as Clinical Investigator at Early Drug Development and Molecular Therapy in Cancer. He has also wide experience in Clinical Trials, specially for Sarcomas.
Medical Doctor. PhD Cell Biology, Autonomous University of Barcelona. Seasoned executive. Professor of Molecular Biology with an extensive international scientific research career in Translational Medicine & Endometrial & Prostate Cancer Biomarkers. Entrepreneur expertise as Founder of Transbiomed Ltd. and Scientific Advisor and Board of Directors Member in Advanced Marker Discovery Ltd. Visiting Investigator at the National Cancer Institute, NIH.